Back to search

United Kingdom· GB-APID-4277911000001106

NatraHealth Glucosamine sulfate 500mg capsules

A glucosamine product containing glucosamine sulfate, registered in United Kingdom by NatraHealth Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC M01AX05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNatraHealth Glucosamine sulfate 500mg…ATCM01AX05REGISTER NO.GB-APID-4277911000001…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Glucosamine is registered in 14 of 19 countries.

Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Glucosamine · ATC M01AX05

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glucosamine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Glucosamine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$0.23
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Glucosamine sulfate
Manufacturer
NatraHealth Ltd
Country
United Kingdom (GB)
ATC code
M01AX05
ATC class
Glucosamine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glucosamine.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glucosamine · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucosamine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucosamine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Cyprus · Donarthril
  • Czechia · Artaxin, Flexove
  • Germany · Glucosamin Doppelherzpharma
  • Spain · Acenam, Duartron
  • Finland · Glucosamin Orion
  • France · Flexea, Osaflexan
  • Greece · Donarot, Energorot
  • Hungary · Cartilamin, Glukozamin Pharma Nord
  • Ireland · Arthrimel, Dona
  • Iceland · Glucomed
  • Norway · Glucosamin Orifarm, Samin
  • Poland · Flexove
  • Portugal · Biartril, Glucomed
  • Sweden · Artroxan, Glucomed
  • Slovakia · Glucomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed98f417-53ce-4037-a813-3e3ada8ff9b8
GET /v1/drugs/ed98f417-53ce-4037-a813-3e3ada8ff9b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4277911000001106",
  "desc": "NatraHealth Glucosamine sulfate 500mg capsules (NatraHealth Ltd)",
  "form": "Oral capsule",
  "vpid": "4283411000001104",
  "source": "dmd",
  "vtm_id": "10043411000001102",
  "strength": null,
  "substance": "Glucosamine sulfate",
  "ingredient": "Glucosamine sulfate",
  "supplier_code": "8801911000001104"
}

See everything about glucosamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.